3[1]Shamim EA,Rider LG,Miller FW,et al.Update on the genetics of the idiopathic inflammatory myopathies[J].Curr Opin Rheumatol,2000,12 (6):482-491.
4[2]Shamim EA,Rider LG,Pandey JP,et al.Differences in idiopathic inflammatory myopathy phenotypes and genotypes between Mesoamerican Mestizos and North American Caucasians[J].Arthritis Rheum,2002,46 (7):1885-1893.
5[3]Rider LG,Artlett CM,Foster CB,et al.Polymorphisms in the IL-1 receptor autagonist gene VNTR are possible risk factors for juvenile idiopathic inflammatory myopathies[J].Clin Exp Immunol,2000,121 (1):47-52.
7[5]Amemiya K,Granger RP,Dalakas MC,et al.Clonal restriction of T-cell receptor expression by infiltrating lymphocytes in inclusion body myositispersists over time.Studies in repeated muscle biopsies[J].Brain,2000,123(10):2030-2039.
8[6]Christense ML,Pachman LM,Schneiderman R,et al.Prevalence of Coxsackie B virus antibodies in patients with juvenile dematomyositis[J].Arthritis Rheum,1986,29(11):1365-1370.
9[7]Sherman MP,Amin RM.Identification of human T cell leukemia/lymphoma virus type Ⅰ antibodies,DNA,and protein in patients with polymyositis[J].Arthritis Rheum,1995,38(5):690-698.
10[8]Baguley E,Wolfe C,Hughes GRV.Dermatomyositis in HIVinfection letter[J].Br J Rheumatol,1988,27:493-494.
